In this study, upregulation of chemokine receptors CCR5 and CCR2—both linked to inflammatory cell migration—was observed, which might be consistent with findings that CCR5 antagonists can improve neurological outcomes post-stroke (Joy et al., 2020; Jing et al., 2023). The gene discussed is CCR5; the disease is stroke disorder.